Stanford Researchers Aim to Speak ‘Brain’s Language’ to Heal Parkinson’s Disease
Researchers at Stanford University are hoping that brain-machine interfaces, or neural prosthetics, could become a clinical reality to help cure …
Articles by Ana de Barros, PhD
Parkinson’s Foundation Launches New Brand, Website Following Merger
Following the recent merger of the National Parkinson Foundation and the Parkinson’s Disease Foundation, the newly created Parkinson’s Foundation has launched…
Purdue Researchers Using Wii Games to Improve Parkinson’s Patients’ Movement, Speech, and Quality of Life
Two Purdue University professors are using the global phenomenon known as the Nintendo Wii gaming system to help Parkinson’s…
Parkinson’s Experts Become Co-directors of New York University Movement Disorders Institute
Two Parkinson’s disease specialists have been named the co-leaders of a New York University movement disorders institute. Drs. Andrew Feigin…
Noncontact Boxing Gaining Popularity as Exercise Option for Patients in the US
Rock Steady Boxing is a nonprofit organization that seeks to improve the quality of life of Parkinson’s disease…
Titan Treats First Parkinson’s Patient with Ropinirole Implant in Clinical Trial
The first patient has been treated in a clinical trial evaluating Titan Pharmaceuticals’ ropinirole implants, designed to treat…
AC Immune Obtaining More Fox Foundation Funding to Continue Developing PET Tracers for Diagnosing Parkinson’s
AC Immune is receiving additional funding from the Michael J. Fox Foundation for Parkinson’s Research to continue developing positron emission…
Herantis Pharma Is Recruiting Patients for Clinical Trial of CDNF as Parkinson’s Treatment
Herantis Pharma has started the first clinical trial of cerebral dopamine neurotrophic factor (CDNF) as a potential treatment…
Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Researchers at Australia’s RMIT University have developed the first tool capable of diagnosing early signs of Parkinson’s disease even before…
Phase 1b Trial of VY-AADC01 Gene Therapy for Advanced Parkinson’s Disease Shows Positive Results
An ongoing Phase 1b trial of VY-AADC01, a gene therapy for the treatment of advanced Parkinson’s disease (PD), is showing…